|
Volumn 14, Issue 10, 2013, Pages 929-930
|
Milk thistle: Early seeds of potential
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ORAL CONTRACEPTIVE AGENT;
PLACEBO;
PROTEINASE INHIBITOR;
SILIBININ;
SILYBIN PHYTOSOME;
SILYBUM MARIANUM EXTRACT;
SILYMARIN;
UNCLASSIFIED DRUG;
ACUTE LEUKEMIA;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ANTIVIRAL ACTIVITY;
APOPTOSIS;
BREAST CANCER;
CANCER CELL;
CANCER CHEMOTHERAPY;
COLON CANCER;
DIARRHEA;
DRUG ABSORPTION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG USE;
DYSPEPSIA;
FLOWER;
GASTROINTESTINAL SYMPTOM;
HEPATITIS C;
HERBAL MEDICINE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTOXICATION;
LIVER CANCER;
LIVER CIRRHOSIS;
LIVER DYSFUNCTION;
LIVER INJURY;
LIVER PROTECTION;
NONHUMAN;
NOTE;
OBSESSIVE COMPULSIVE DISORDER;
PLANT LEAF;
PRIORITY JOURNAL;
PROSTATE CANCER;
SIDE EFFECT;
SILYBUM MARIANUM;
SKIN CANCER;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
MILK THISTLE;
NEOPLASMS;
PHYTOTHERAPY;
SILYMARIN;
|
EID: 84882948298
PISSN: 14702045
EISSN: 14745488
Source Type: Journal
DOI: 10.1016/S1470-2045(13)70414-5 Document Type: Note |
Times cited : (27)
|
References (0)
|